1Prinz JC,Gross B, Vollmer S,et al. T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products. Eur J Immunol, 1994, 24: 593-598.
2Demidem A,Taylor JR, Grammer SF, et al. T-lymphocyte-activating properties of epidermal antigen-presenting cells from normal and psoriatic skin: evidence that psoriatic epidermal antigen-presenting cells resemble cultured normal Langerhans cells. J Invest
3Langlois MR,Delanghe JR.Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem, 1996, 42:1589-1600.
4Xie Y,Li Y,Zhang Q, et al.Haptoglobin is a natural regulator of Langerhans cell function in the skin. J Dermatol Sci, 2000, 24:25-37.
5Xie Y,Streilein JW. Regulation of Langerhans cell function via blood borne factor(s). J Dermatol Sci, 1996, 12: 263-274.
6Debets R, Hegmans JP, Croughs P,et al. The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis. J Immunol, 1997, 158: 2955-2963.
7Bieber T, Ring J, Braun-Falco O.Comparison of different methods for enumeration of Langerhans cells in vertical cryosections of human skin. Br J Dermatol, 1988, 118: 385-392.
8Griffiths CE, Railan D, Gallatin WM,et al. The ICAM-3/LFA-1 interaction is critical for epidermal Langerhans cell alloantigen presentation to CD4+ T cells. Br J Dermatol, 1995, 133: 823-829.
9Zemelman V, Van Neer F,Roberts N,et al. Epidermal Langerhans cells, HIV-1 infection and psoriasis. Br J Dermatol, 1994, 130:307-311.
10Langlois MR, Delanghe JR. Biological and clinical significant of haptoglobin polymorphism in humans. Clin Chem, 1996, 42: 1589-1600.
